ISSN: 2155-9570
Ruchi Shrestha
Age related macular degeneration is a multifactorial disease involving genetic and environmental factors. Newer drugs targeting complement pathway (Eculizumab, Lampalizumab), gene therapy and stem cell therapy are recent innovations for the treatment of age related macular degeneration.